Compounds > adamantane
Page last updated: 2024-08-21

adamantane and B16 Melanoma

adamantane has been researched along with B16 Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baek, HS; Jang, WH; Joo, YH; Jung, K; Lee, CS; Lim, KM; Park, M; Park, YH1
Beak, HS; Joo, YH; Kim, BJ; Kim, JH; Kwon, TR; Lee, CS; Lee, JH; Oh, CT; Park, ES; Shin, HJ; Shin, SS1
Górska, A; Kazimierczuk, Z; Lasek, W; Switaj, T1

Other Studies

3 other study(ies) available for adamantane and B16 Melanoma

ArticleYear
A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression.
    Experimental dermatology, 2013, Volume: 22, Issue:11

    Topics: Adamantane; Animals; Benzamides; Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Humans; Hyperpigmentation; Melanins; Melanocytes; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Signal Transduction; Skin; Skin Neoplasms

2013
A novel adamantyl benzylbenzamide derivative, AP736, inhibits melanogenesis in B16F10 mouse melanoma cells via glycogen synthase kinase 3β phosphorylation.
    International journal of molecular medicine, 2015, Volume: 36, Issue:5

    Topics: Adamantane; Animals; Benzamides; beta Catenin; Carcinogenesis; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Melanins; Melanocytes; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Phosphorylation; Wnt Signaling Pathway

2015
Adamantylaminopyrimidines and -pyridines are potent inducers of tumor necrosis factor-alpha.
    Bioorganic & medicinal chemistry letters, 2001, May-07, Volume: 11, Issue:9

    Topics: Adamantane; Animals; Chromatography; Melanoma, Experimental; Mice; Pyridines; Pyrimidines; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2001